|
Announcements
BECKMAN COULTER, INC. SELECTS CLINIVATION'S GLOBAL MARKET CLEARANCE SERVICES
Global leader in the manufacturing of biomedical testing instrument systems, tests and supplies for automated
laboratory processes selects clinivation's Global Market Clearance Services to position their operations
for continued growth and successful expansion.
Natick, MA, June 12, 2009 - clinivation, Inc. announced today that Beckman Coulter, Inc.
has selected clinivation's Global Market Clearance Services.
"Beckman Coulter is one of America's largest biomedical companies.
Beckman Coulter develops, manufactures and markets products that
simplify, automate and innovate complex biomedical tests. We are
pleased that they have selected clinivation's Global Market Clearance
Services to position their operations for continued growth and successful
expansion," said Richard Morroney, R.A.C., C.Q.A., clinivation's
Vice President, Global Market Clearance Solutions.
About clinivation's Global Market Clearance Services
Clinivation's Global Market Clearance services leverage our excellence in market clearance and
many years of focused, successful experience in developing and supporting thousands
of medtech market clearance applications in all of the major and emerging world
markets. Our many years of successful experience spans from comprehensive initiation,
support, and execution of the most complex Class III PMA programs to focused global
market clearance initiatives.
About Beckman Coulter, Inc.
Beckman Coulter, Inc. is a leading manufacturer of biomedical testing instrument systems, tests and
supplies that simplify and automate laboratory processes. Spanning the biomedical testing continuum-from
pioneering medical research and clinical trials to laboratory diagnostics and point-of-care testing-Beckman
Coulter's 200,000 installed systems provide essential biomedical information to enhance health care around
the world. The company, based in Fullerton, Calif., reported 2007 annual sales of $2.76 billion with more
than 78 percent of this amount generated by recurring revenue from supplies, test kits and services.
For more information, please visit www.beckmancoulter.com.
About clinivation, Inc. Clinivation
is the leading provider of integrated solutions that enable global market clearance.
Guided by our singular vision - "Excellence in Market Clearance" - clinivation
accelerates the entire market clearance cycle to advance new worldwide revenue
and achieve new milestones of enterprise value. Used in over 1,000,000 product
registrations by more than 100 companies worldwide, clinivation's end-to-end technology
and services deliver on our vision by eliminating revenue traps from global market
clearance operations, increasing process velocity with on-demand regulatory intelligence,
automating clearance-driven business controls, simplifying content unification
into market clearance applications, aligning quality systems with global market
clearance priorities, streamlining clinical development with clearance-focused
trials, and enabling management with key performance indicators for continuous
improvement and effective governance. The world's leading medical device,
diagnostics, hospital supply, and dental supply companies select clinivation because
of our medtech industry focus and our unique, integrated solutions that seamlessly
adapt to existing business processes and enterprise infrastructure- without the
need to write custom code. Our core brands include the clinivation Global®
xi market clearance platform, clinivation WorldView® on-demand
regulatory intelligence, and clinivation Clinical Suite® and clinivation
Registry Suite® electronic data capture and clinical data management
software. Founded in 1999, the company is headquartered in Natick, Massachusetts,
with regional offices in North America and Asia. Visit clinivation online
at www.clinivation.com For
further information: For more information on clinivation's
integrated solutions that enable global market clearance, please click
here or call us at 508.655.6560. | 
